HomeCompareRYOFX vs JNJ

RYOFX vs JNJ: Dividend Comparison 2026

RYOFX yields 9.06% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYOFX wins by $16.4K in total portfolio value
10 years
RYOFX
RYOFX
● Live price
9.06%
Share price
$15.27
Annual div
$1.38
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36.4K
Annual income
$1,603.70
Full RYOFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RYOFX vs JNJ

📍 RYOFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYOFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYOFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYOFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYOFX
Annual income on $10K today (after 15% tax)
$770.01/yr
After 10yr DRIP, annual income (after tax)
$1,363.15/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RYOFX beats the other by $659.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYOFX + JNJ for your $10,000?

RYOFX: 50%JNJ: 50%
100% JNJ50/50100% RYOFX
Portfolio after 10yr
$28.2K
Annual income
$1,215.74/yr
Blended yield
4.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYOFX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYOFX buys
0
JNJ buys
0
No recent congressional trades found for RYOFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYOFXJNJ
Forward yield9.06%3.36%
Annual dividend / share$1.38$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$36.4K$20.0K
Annual income after 10y$1,603.70$827.78
Total dividends collected$12.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RYOFX vs JNJ ($10,000, DRIP)

YearRYOFX PortfolioRYOFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,606$905.89$10,676$355.77+$930.00RYOFX
2$13,401$982.59$11,407$389.39+$2.0KRYOFX
3$15,399$1,060.34$12,198$426.53+$3.2KRYOFX
4$17,616$1,138.75$13,056$467.62+$4.6KRYOFX
5$20,067$1,217.44$13,987$513.12+$6.1KRYOFX
6$22,767$1,296.08$14,998$563.56+$7.8KRYOFX
7$25,735$1,374.31$16,098$619.52+$9.6KRYOFX
8$28,989$1,451.85$17,295$681.69+$11.7KRYOFX
9$32,546$1,528.39$18,599$750.82+$13.9KRYOFX
10$36,428$1,603.70$20,022$827.78+$16.4KRYOFX

RYOFX vs JNJ: Complete Analysis 2026

RYOFXStock

The investment seeks long-term growth of capital. The fund&#39;s investment adviser invests the fund&#39;s assets primarily in equity securities of small- and micro-cap companies in an attempt to take advantage of what it believes are opportunistic situations for undervalued securities. Normally, the fund invests at least 65% of its net assets in equity securities. It may invest in other investment companies that invest in equity securities.

Full RYOFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RYOFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYOFX vs SCHDRYOFX vs JEPIRYOFX vs ORYOFX vs KORYOFX vs MAINRYOFX vs ABBVRYOFX vs MRKRYOFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.